You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
25 September 2026 - The University of Chicago Medicine announced on Thursday the completion of the construction phase of the AbbVie Foundation Cancer Pavilion.Scheduled to open in April 2027 on UChicago Medicine's main campus in Hyde Park on the...
25 September 2026 - Biotechnology company REGENXBIO Inc (Nasdaq:RGNX) on Thursday announced positive long-term follow-up data from the Phase II ALTITUDE study of investigational surabgene lomparvovec (sura-vec, ABBV-RGX-314) in diabetic retinopathy (...
25 September 2026 - XtalPi (HKEX:2228), an AI- and robotics-driven drug and materials discovery company, announced on Thursday the submission of an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) for KQTD-126.T...
24 September 2026 - Life sciences and diagnostics company Revvity Inc (NYSE:RVTY) on Thursday launched the GSP T1D 3plex kit, a fully automated, CE-IVDR-certified multiplex autoantibody detection solution designed to support population-wide screening...
24 September 2026 - GRAIL Inc, a healthcare company focused on early cancer detection,, announced on Wednesday a favourable vote from the Molecular and Clinical Genetics Devices Panel of the Medical Devices Advisory Committee of the US Food and Drug ...
24 September 2026 - Japanese pharmaceutical company Astellas Pharma Inc (TSE:4503) announced on Wednesday that the first patient has been dosed in a Phase 3 study evaluating setidegrasib, a novel, investigational KRAS G12D-targeted protein degrader, ...
23 September 2026 - Biopharmaceutical company AstraZeneca (LSE: AZN) (STO: AZN) (NYSE: AZN) declared on Wednesday that it has received European Commission approval for Trixeo Aerosphere as a maintenance treatment for asthma in patients aged 12 and ov...